Mar 10, 2020

How can single cell immune profiling support infectious disease research?

Liz Lucero

Research case studies demonstrate the utility of single cell immune profiling to advance infectious disease research. Watch our on-demand webinar.

Infectious diseases represent a serious threat to human health, and in light of recent global health concerns around viral outbreaks, the ability of the scientific community to respond quickly to events like this is as essential as ever. Human health relies on the immune system’s ability to defend the body against infection, and a comprehensive characterization of the immune response to infection may be the key to unlocking novel or improved vaccine therapies for infectious diseases like influenza, dengue virus, HIV and even the recent coronavirus.

Recent innovations in single cell immune profiling technology are advancing infectious disease research, providing deeper insight into the biology of infectious diseases and the adaptive immune response. The scientific community can now address key questions about virus biology, as well as the human immune response, cell by cell. With the Chromium Single Cell Immune Profiling Solution, scientists can combine multidimensional readouts of immune cell biology, including phenotype, gene expression, and immune receptor sequences at single cell resolution. This data can provide information not only about how an individual cell functions before and after infection, but about the larger immune response, allowing scientists to delve into the mechanisms driving infectious diseases, and, ultimately, develop potential treatments.

Learn more about how single cell immune profiling capabilities can impact your infectious disease research by watching our latest On-Demand Webinar.

In this on-demand webinar, you can explore:

  • Publications that showcase the utility of single cell immune profiling to reveal insights into the immune response that remain hidden with flow cytometry analysis alone
  • Novel experimental workflows to accelerate antibody discovery and validation, including LIBRA-seq, a method that maps B-cell receptor sequences to antigen specificity

And much more. Watch now!